Trends in hospitalization for community-associated methicillin- resistant staphylococcus aureus in New York city, 1997-2006: Data from New York state's statewide planning and research cooperative system

Infection Control and Hospital Epidemiology

Volumn 33, Issue 7, 2012, Pages 725-731

  Farr, Amanda M ^a   Aden, Brandon ^b   Weiss, Don ^c   Nash, Denis ^d   Marx, Melissa A ^e  

^a Custom Data Analytics   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HOMELESSNESS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; RETROSPECTIVE STUDY; SEX DIFFERENCE; UNITED STATES;

ADOLESCENT; ADULT; AGED; CROSS INFECTION; FEMALE; HOSPITALIZATION; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NEW YORK; NEW YORK CITY; POPULATION SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84863193994     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/666329     Document Type: Article

References (38)

1. Barber M. Naturally occurring methicillin-resistant staphylococci. J Gen Microbiol 1964;35:183-190.
2. Saravolatz L, Markowitz N. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a communityacquired outbreak. Ann Int Med 1982;96(1):11-16.
3. Herold B, Immergluck L, Maranan MC, et al. Communityacquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk factor. JAMA 1998;279: 593-598.
4. Como-Sabetti K, Harriman KH, Buck JM, Glennen A, Boxrud DJ, Lynfield R. Community-associated methicillin-resistant Staphylococcus aureus: trends in case and isolate characteristics from six years of prospective surveillance. Public Health Rep 2009;124:427-435.
5. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005;40:1785-1791.
6. Begier EM, Frenette K, Barrett NL, et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 2004;39:1446-1453.
7. Lowy FD, Aiello AE, Bhat M, et al. Staphylococcus aureus colonization and infection in New York State prisons. J Infect Dis 2007;196:911-918.
8. Centers for Disease Control and Prevention. Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003;52:88.
9. Sztramko R, Katz K, Antoniou T, et al. Community-associated methicillin-resistant Staphylococcus aureus infections in men who have sex with men: a case series. Can J Infect Dis Med Microbiol 2007;18:257-261.
10. Statewide Planning and Research Cooperative System (SPARCS). New York State website. http://www.health.ny.gov/statistics /sparcs/. Published 2009. Accessed June 22, 2009.
11. Frei CR, Makos BR, Daniels KR, Oramasionwu CU. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. J Pediatr Surg 2010;45: 1967-1974.
12. Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis 2009;491:65-71.
13. Popovic JR. 1999 National hospital discharge survey: annual summary with detailed diagnosis and procedure data. Vital Health Stat 13 2001;151:i-v, 1-206.
14. Neighborhood population estimates. New York City Department of Health and Mental Hygiene website. http://www.nyc.gov/html/doh/html/episrv/popest_methods.shtml#5. Published 2010. Accessed February 14, 2010.
15. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-1771.
16. Fridkin S, Hageman J, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-1444.
17. Olson E, Van Wye G, Kerker B, Thorpe L, Frieden T. Take Care Southeast Bronx. New York City Department of Health andMental Hygiene website. http://www.nyc.gov/html/doh/downloads /pdf/data/2006chp-104.pdf. Published 2006. Accessed September 1, 2009.
18. Epiquery: NYC interactive health data system-community health survey, 2006. New York City website. http://nyc.gov /health/epiquery. Published 2009. Accessed August 24, 2009.
19. Young DM, Harris HW, Charlebois ED, et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg 2004;139: 947-951; discussion, 951-953.
20. Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005;45:311-320.
21. Turabelidze G, Lin M, Wolkoff B, Dodson D, Gladbach S, Zhu BP. Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerg Infect Dis 2006;12:422-427.
22. Nguyen DM, Mascola L, Brancoft E. Recurring methicillinresistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 2005;11:526-532.
23. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003;52: 793-795.
24. Marx MA, Cook H, Rehana Z, et al. Results of a case-control investigation of risk factors for CA-MRSA in New York City, 2005-2007. In: Final Program and Abstract Book of 2008 Annual Conference on Antimicrobial Resistance. Bethesda, MD; June 23-25, 2008. Abstract S7.
25. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008;148:249-257.
26. Crum-Cianflone NF, Burgi AA, Hale BR. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. Int J STD AIDS 2007;18:521-526.
27. Trinh TT, Short WR, Mermel LA. Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected patients. J Int Assoc Physicians AIDS Care (Chic) 2009;8:176-180.
28. Mathews WC, Caperna JC, Barber RE, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005;40:155-160.
29. Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1989;125:357-361.
30. Smith KJ, Skelton HG, Yeager J, et al; Military Medical Consortium for the Advancement of Retroviral Research. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. J Am Acad Dermatol 1994;31:746-754.
31. Rubinstein R, Genaro AM, Motta A, Cremaschi G, Wald MR. Impaired immune responses in streptozotocin-induced type I diabetes in mice: involvement of high glucose. Clin Exp Immunol 2008;154:235-246.
32. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003;26:510-513.
33. Conversion Table of New ICD-9-CM Codes, October 2011. Centers for Disease Control and Prevention National Center for Health Statistics website. http://www.cdc.gov/nchs/data/icd9/CNVTB12.pdf Published 2011. Accessed January 6, 2012.
34. Byrd KK, Holman RC, Bruce MG, et al. Methicillin-resistant Staphylococcus aureus-associated hospitalizations among the American Indian and Alaska Native population. Clin Infect Dis 2009;49:1009-1015.
35. Herigon JC, Hersh AL, Gerber JS, Zaoutis TE, Newland JG. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008. Pediatrics 2011;125: e1294-e1300.
36. Caffrey AR, Quilliam BJ, LaPlante KL. Comparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010;54:4394-4400.
37. Schweizer ML, Eber MR, Laxminarayan R, et al. Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol 2011;32: 148-154.
38. Schaefer MK, Ellingson K, Conover C, et al. Evaluation of International Classification of Diseases, Ninth Revision, Clinical Modification codes for reporting methicillin-resistant Staphylococcus aureus infections at a hospital in Illinois. Infect Control Hosp Epidemiol 2010;31:463-468.